Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Foot and Ankle Research
Published in: Journal of Foot and Ankle Research 1/2013

Open Access 01-12-2013 | Commentary

Neurologist practice patterns in treatment of muscle cramps in Canada

Authors: Mary Jane Lim Fat, Seint Kokokyi, Hans Dieter Katzberg

Published in: Journal of Foot and Ankle Research | Issue 1/2013

Login to get access

Abstract

Recently an article provided patient perspectives on therapies and perceived effectiveness in preventing muscle cramps. However, there are few studies evaluating physicians’ point of view in the management of this common symptom. In our study, we studied physician practice patterns in the treatment of muscle cramps by surveying a group of neurologists in Canada. We demonstrated that most physicians use a combination of pharmacological and non-pharmacological methods in treating muscle cramps. The most commonly used medications are baclofen, quinine and gabapentin, of which baclofen and quinine were reported to be the most tolerated.
Literature
1.
Blyton F, Chuter V, Burns J: Unknotting night-time muscle cramp: a survey of patient experience, help-seeking behaviour and perceived treatment effectiveness. J Foot Ankle Res. 2012, 5: 7-10.1186/1757-1146-5-7.CrossRefPubMedPubMedCentral
2.
Katzberg HD, Khan AH, So YT: Assessment: Symptomatic treatment for muscle cramps (an evidence-based review): Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology. 2010, 74 (8): 691-696. 10.1212/WNL.0b013e3181d0ccca.CrossRefPubMed
3.
Food and Drug Administration: Department of Health and Human Services. Drug products containing quinine; enforcement action dates. Fed Regist. 2006, 71: 75557-75560.
4.
Quinine indications - cramps deleted. Aust Adv Drug React Bull. 2004, 23:
5.
El-Tawil S, Al Musa T, Valli H, Lunn MP, El-Tawil T, Weber M: Quinine for muscle cramps. Cochrane Database Syst Rev. 2010, 8: 12-
6.
Garrison SR, Colin RD, Morrow RL, Carney GA, Khan KM: Nocturnal leg cramps and prescription use that precedes them: A sequence symmetry analysis. Arch of Int Med. 2012, 172: 120-126. 10.1001/archinternmed.2011.1029.CrossRef
Metadata
Title
Neurologist practice patterns in treatment of muscle cramps in Canada
Authors
Mary Jane Lim Fat
Seint Kokokyi
Hans Dieter Katzberg
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Foot and Ankle Research / Issue 1/2013
Electronic ISSN: 1757-1146
DOI
https://doi.org/10.1186/1757-1146-6-2

Other articles of this Issue 1/2013

Journal of Foot and Ankle Research 1/2013 Go to the issue

Research

Understanding the physical activity promotion behaviours of podiatrists: a qualitative study

Methodology

Reliability of ultrasound to measure morphology of the toe flexor muscles

Review

Interventions for increasing ankle joint dorsiflexion: a systematic review and meta-analysis

Research

Factors affecting center of pressure in older adults: the Framingham Foot Study

Research

Hallux valgus and plantar pressure loading: the Framingham foot study

Review

A review of the foot function index and the foot function index – revised